This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
After having to halt enrollment in its severe COVID-19 trial due to a lack of patients,...
The Irish company Avectas has closed a Series C round to develop cell therapies...
Australia’s largest biotech company CSL says it is working on a plasma-based therapy...
The big pharma lowered its sales guidance Tuesday as it begins to see the effects...
Just a month after getting its BLA accepted by the FDA for its next-gen breast cancer...
The chief executive of infectious disease biotech Vir, George Scangos, has been...
The alliance, which currently includes four other companies, is looking to speed...